{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:17:21Z","timestamp":1757618241203,"version":"3.44.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["R25MH135837"],"award-info":[{"award-number":["R25MH135837"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Immigrant Minority Health"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10903-025-01702-0","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T03:25:21Z","timestamp":1749439521000},"page":"518-522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investing in Group Psychedelic Therapy for Latinx Immigrants"],"prefix":"10.1007","volume":"27","author":[{"given":"Juliana","family":"Zambrano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Espi\u00a0Forcen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franklin","family":"King,\u00a0IV","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"1","key":"1702_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10488-008-0197-4","volume":"36","author":"EK Proctor","year":"2009","unstructured":"Proctor EK, et al. Implementation research in mental health services: an emerging science with conceptual, methodological, and training challenges. Adm Policy Ment Health. 2009;36(1):24\u201334.","journal-title":"Adm Policy Ment Health"},{"issue":"6","key":"1702_CR2","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1177\/1745691620927709","volume":"15","author":"SO Roberts","year":"2020","unstructured":"Roberts SO, et al. Racial inequality in psychological research: trends of the past and recommendations for the future. Perspect Psychol Sci. 2020;15(6):1295\u2013309.","journal-title":"Perspect Psychol Sci"},{"issue":"10077","key":"1702_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","volume":"389","author":"ZD Bailey","year":"2017","unstructured":"Bailey ZD, et al. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453\u201363.","journal-title":"Lancet"},{"issue":"1","key":"1702_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12888-018-1824-6","volume":"18","author":"TI Michaels","year":"2018","unstructured":"Michaels TI, et al. Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature. BMC Psychiatry. 2018;18(1):245.","journal-title":"BMC Psychiatry"},{"key":"1702_CR5","doi-asserted-by":"publisher","first-page":"102711","DOI":"10.1016\/j.eclinm.2024.102711","volume":"74","author":"ME Hughes","year":"2024","unstructured":"Hughes ME, Garcia-Romeu A. Ethnoracial inclusion in clinical trials of psychedelics: a systematic review. EClinicalMedicine. 2024;74:102711.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"1702_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1556\/2054.2019.032","volume":"4","author":"MT Williams","year":"2020","unstructured":"Williams MT, Labate BC. Diversity, equity, and access in psychedelic medicine. J Psychedelic Stud. 2020;4(1):1\u20133.","journal-title":"J Psychedelic Stud"},{"key":"1702_CR7","unstructured":"Bureau USC. Hispanic Origin. 2020."},{"key":"1702_CR8","unstructured":"Hamilton D, et al. U.S. Latino GDP report. the Latino Donor Collaborative; 2024."},{"key":"1702_CR9","unstructured":"Moslimani MP, Jeffrey S. Key findings about U.S. immigrants. 2024."},{"key":"1702_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3928\/00485713-20230215-02","volume":"53","author":"F Espi-Forc\u00e9n","year":"2023","unstructured":"Espi-Forc\u00e9n F, et al. Deconstructing cultural aspects of mental health care in Hispanic\/Latinx people. Psychiatric Annals. 2023;53:127\u201332.","journal-title":"Psychiatric Annals"},{"issue":"3","key":"1702_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s10488-006-0040-8","volume":"33","author":"LJ Cabassa","year":"2006","unstructured":"Cabassa LJ, Zayas LH, Hansen MC. Latino adults\u2019 access to mental health care: a review of epidemiological studies. Adm Policy Ment Health. 2006;33(3):316\u201330.","journal-title":"Adm Policy Ment Health"},{"key":"1702_CR12","unstructured":"SAMHSA, National Survey on Drug Use and Health (NSDUH): Hispanics, Latino, or Spanish Origin or Descent. 2018."},{"issue":"5","key":"1702_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","volume":"177","author":"CM Reiff","year":"2020","unstructured":"Reiff CM, et al. Psychedelics and Psychedelic-Assisted psychotherapy. Am J Psychiatry. 2020;177(5):391\u2013410.","journal-title":"Am J Psychiatry"},{"key":"1702_CR14","doi-asserted-by":"crossref","unstructured":"Erritzoe D et al. Effect of psilocybin versus Escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial. EClinicalMedicine, 2024.","DOI":"10.1016\/j.eclinm.2024.102799"},{"key":"1702_CR15","doi-asserted-by":"crossref","unstructured":"Sessa B, Higbed L, Nutt D. A review of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy. Front Psychiatry, 2019: 10.","DOI":"10.3389\/fpsyt.2019.00138"},{"issue":"1","key":"1702_CR16","first-page":"33","volume":"34","author":"MD Kritzer","year":"2022","unstructured":"Kritzer MD, et al. Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress. Ann Clin Psychiatry. 2022;34(1):33\u201343.","journal-title":"Ann Clin Psychiatry"},{"issue":"1","key":"1702_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/1751696X.2014.993244","volume":"8","author":"E Guerra-Doce","year":"2015","unstructured":"Guerra-Doce E. Psychoactive substances in prehistoric times: examining the archaeological evidence. Time Mind. 2015;8(1):91\u2013112.","journal-title":"Time Mind"},{"issue":"1","key":"1702_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.9740\/mhc.2017.01.039","volume":"7","author":"BJ Malcolm","year":"2017","unstructured":"Malcolm BJ, Lee KC. Ayahuasca: an ancient sacrament for treatment of contemporary psychiatric illness? Ment Health Clin. 2017;7(1):39\u201345.","journal-title":"Ment Health Clin"},{"key":"1702_CR19","doi-asserted-by":"publisher","first-page":"104242","DOI":"10.1016\/j.ajp.2024.104242","volume":"102","author":"HK Behera","year":"2024","unstructured":"Behera HK, et al. Exploring the regulatory framework of psychedelics in the US & Europe. Asian J Psychiatr. 2024;102:104242.","journal-title":"Asian J Psychiatr"},{"issue":"1","key":"1702_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMp1903305","volume":"381","author":"J Kim","year":"2019","unstructured":"Kim J, et al. Esketamine for Treatment-Resistant Depression - First FDA-Approved antidepressant in a new class. N Engl J Med. 2019;381(1):1\u20134.","journal-title":"N Engl J Med"},{"issue":"5","key":"1702_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","volume":"178","author":"RS McIntyre","year":"2021","unstructured":"McIntyre RS, et al. Synthesizing the evidence for ketamine and Esketamine in Treatment-Resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383\u201399.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1702_CR22","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1192\/bjo.2021.1061","volume":"8","author":"Z Walsh","year":"2021","unstructured":"Walsh Z, et al. Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review. BJPsych Open. 2021;8(1):e19.","journal-title":"BJPsych Open"},{"issue":"1","key":"1702_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41398-023-02451-0","volume":"13","author":"J Kopelman","year":"2023","unstructured":"Kopelman J, et al. Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression. Translational Psychiatry. 2023;13(1):159.","journal-title":"Translational Psychiatry"},{"issue":"4","key":"1702_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/0269881120959637","volume":"35","author":"A Brouwer","year":"2021","unstructured":"Brouwer A, Carhart-Harris RL. Pivotal mental States. J Psychopharmacol. 2021;35(4):319\u201352.","journal-title":"J Psychopharmacol"},{"issue":"2","key":"1702_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/02791072.2019.1587556","volume":"51","author":"J Dore","year":"2019","unstructured":"Dore J, et al. Ketamine assisted psychotherapy (KAP): patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy. J Psychoact Drugs. 2019;51(2):189\u201398.","journal-title":"J Psychoact Drugs"},{"key":"1702_CR26","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2147\/JPR.S360733","volume":"15","author":"SJ Drozdz","year":"2022","unstructured":"Drozdz SJ, et al. Ketamine assisted psychotherapy: A systematic narrative review of the literature. J Pain Res. 2022;15:1691\u2013706.","journal-title":"J Pain Res"},{"key":"1702_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jad.2022.07.030","volume":"315","author":"I Joneborg","year":"2022","unstructured":"Joneborg I, et al. Active mechanisms of ketamine-assisted psychotherapy: A systematic review. J Affect Disord. 2022;315:105\u201312.","journal-title":"J Affect Disord"},{"key":"1702_CR28","first-page":"868103","volume":"13","author":"DS Mathai","year":"2022","unstructured":"Mathai DS, Mora V, Garcia-Romeu A. Toward Synergies Ketamine Psychother Front Psychol. 2022;13:868103.","journal-title":"Toward Synergies Ketamine Psychother Front Psychol"},{"issue":"3","key":"1702_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1017\/S1092852919001007","volume":"25","author":"G Hasler","year":"2020","unstructured":"Hasler G. Toward specific ways to combine ketamine and psychotherapy in treating depression. CNS Spectr. 2020;25(3):445\u20137.","journal-title":"CNS Spectr"},{"key":"1702_CR30","doi-asserted-by":"crossref","unstructured":"Davis A, Mangini P, Xin Y. Ketamine-assisted psychotherapy for trauma-exposed patients in an outpatient setting: A clinical chart review study. J Psychedelic Stud, 2021: 5.","DOI":"10.1556\/2054.2021.30000"},{"issue":"2","key":"1702_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/00207284.1987.11491473","volume":"37","author":"V McKinley","year":"1987","unstructured":"McKinley V. Group therapy as a treatment modality of special value for Hispanic patients. Int J Group Psychother. 1987;37(2):255\u201368.","journal-title":"Int J Group Psychother"},{"key":"1702_CR32","doi-asserted-by":"publisher","first-page":"152394","DOI":"10.1016\/j.comppsych.2023.152394","volume":"124","author":"T Cruwys","year":"2023","unstructured":"Cruwys T, et al. Therapists who foster social identification build stronger therapeutic working alliance and have better client outcomes. Compr Psychiatry. 2023;124:152394.","journal-title":"Compr Psychiatry"},{"issue":"1","key":"1702_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/cou0000643","volume":"70","author":"YL Garrison","year":"2023","unstructured":"Garrison YL, et al. A qualitative study of women of color group psychotherapists: the wellspring of collective healing. J Couns Psychol. 2023;70(1):1\u201315.","journal-title":"J Couns Psychol"},{"issue":"1","key":"1702_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01612840.2024.2302786","volume":"45","author":"SP Thomas","year":"2024","unstructured":"Thomas SP. The loneliness epidemic and its health consequences. Issues Ment Health Nurs. 2024;45(1):1\u20132.","journal-title":"Issues Ment Health Nurs"},{"key":"1702_CR35","doi-asserted-by":"publisher","first-page":"623985","DOI":"10.3389\/fphar.2021.623985","volume":"12","author":"H Kettner","year":"2021","unstructured":"Kettner H, et al. Psychedelic communitas: intersubjective experience during psychedelic group sessions predicts enduring changes in psychological wellbeing and social connectedness. Front Pharmacol. 2021;12:623985.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1702_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/02791072.2019.1593559","volume":"51","author":"A Trope","year":"2019","unstructured":"Trope A, et al. Psychedelic-Assisted group therapy: A systematic review. J Psychoactive Drugs. 2019;51(2):174\u201388.","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"1702_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jpainsymman.2023.06.006","volume":"66","author":"BR Lewis","year":"2023","unstructured":"Lewis BR, et al. HOPE: A pilot study of psilocybin enhanced group psychotherapy in patients with Cancer. J Pain Symptom Manage. 2023;66(3):258\u201369.","journal-title":"J Pain Symptom Manage"},{"key":"1702_CR38","doi-asserted-by":"publisher","first-page":"100538","DOI":"10.1016\/j.eclinm.2020.100538","volume":"27","author":"BT Anderson","year":"2020","unstructured":"Anderson BT, et al. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study. EClinicalMedicine. 2020;27:100538.","journal-title":"EClinicalMedicine"},{"key":"1702_CR39","unstructured":"Stauffer C. Group MDMA-therapy for Veterans With PTSD (Group-MVP). 2023."},{"issue":"5","key":"1702_CR40","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/02791072.2023.2258120","volume":"55","author":"E Manson","year":"2023","unstructured":"Manson E, et al. Indigenous voices in psychedelic therapy: experiential learnings from a Community-Based group psychedelic therapy program. J Psychoact Drugs. 2023;55(5):539\u201348.","journal-title":"J Psychoact Drugs"},{"issue":"1","key":"1702_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/02791072.2023.2186285","volume":"56","author":"R Robison","year":"2024","unstructured":"Robison R, et al. Ketamine-Assisted group psychotherapy for frontline healthcare workers with COVID-19-Related burnout and PTSD: A case series of effectiveness\/safety for 10 participants. J Psychoact Drugs. 2024;56(1):23\u201332.","journal-title":"J Psychoact Drugs"},{"key":"1702_CR42","doi-asserted-by":"publisher","first-page":"1293243","DOI":"10.3389\/fpsyt.2023.1293243","volume":"14","author":"E Marseille","year":"2023","unstructured":"Marseille E, et al. Group psychedelic therapy: empirical estimates of cost-savings and improved access. Front Psychiatry. 2023;14:1293243.","journal-title":"Front Psychiatry"},{"issue":"6","key":"1702_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11121-017-0806-0","volume":"18","author":"G Bernal","year":"2017","unstructured":"Bernal G, Adames C. Cultural adaptations: conceptual, ethical, contextual, and methodological issues for working with ethnocultural and Majority-World populations. Prev Sci. 2017;18(6):681\u20138.","journal-title":"Prev Sci"},{"issue":"2","key":"1702_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1556\/2054.2023.00283","volume":"7","author":"T-i Dowie","year":"2023","unstructured":"Dowie T-i, Tempone-Wiltshire J. Philosophy and psychedelics: frameworks for exceptional experience. J Psychedelic Stud. 2023;7(2):143\u201350.","journal-title":"J Psychedelic Stud"}],"container-title":["Journal of Immigrant and Minority Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10903-025-01702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10903-025-01702-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10903-025-01702-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:14:57Z","timestamp":1757186097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10903-025-01702-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1702"],"URL":"https:\/\/doi.org\/10.1007\/s10903-025-01702-0","relation":{},"ISSN":["1557-1912","1557-1920"],"issn-type":[{"type":"print","value":"1557-1912"},{"type":"electronic","value":"1557-1920"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"13 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}